The Pharmaceutical Benefits Advisory Committee will reconsider a proposal to broaden the PBS listing of immunotherapies to include current and future TGA indications.
'Initial guidance on parameters that need to be considered for future broad PBS listing proposals'
September 1, 2024 Latest NewsBioPharmaNews of the DayLatest Video
New Stories
-
Patients do not live their condition as aggregated economic models
January 14, 2025 - - Latest News -
Delays were the intended outcome, not an unintended consequence
January 13, 2025 - - Latest News -
Attitudes may have evolved, but the framework they created remains virtually unchanged
January 13, 2025 - - Latest News -
Boehringer Ingelheim's Auckland office leads sustainability in NZ pharma sector
January 10, 2025 - - Latest News -
Companies welcome November PBAC outcomes
December 23, 2024 - - Latest News -
The 'Dispatched' Podcast - 'This draws a line through everything and it's not good'
December 22, 2024 - - Podcast -
'Found irregularities and anomalies in the instruments of delegation from the minister'
December 20, 2024 - - Latest News